Non-Monoaminergig Transmitters, Glia Cell Markers, Cell Adhesion Molecules and Synaptic Proteins in Postmortem Brain Tissue

  • Dan Rujescu
  • Peter Riederer
Part of the Neurobiological Foundation of Aberrant Behaviors book series (NFAB, volume 4)


Attempts to transfer findings gained in animal experiments to human depression have raised doubt that altered monoaminergic neurotransmission can fully explain the pathobiology of depression. This review gives a summary of postmortem findings in affective disorders with regard to nonmonoaminergic neurotransmitter systems, glia cell markers, cell adhesion molecules and synaptic proteins. Only relatively few postmortem studies have examined these gene products in affective disorders and a systematic approach together with the application of modern techniques will hopefully reveal unexpected and exiting findings in the near future.


Bipolar Disorder Frontal Cortex Affective Disorder Vasoactive Intestinal Peptide Synaptic Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Birkmayer W, Riederer P. Biochemical postmortem findings in depressed patients. J Neural Transm 1975; 37: 95–109.PubMedCrossRefGoogle Scholar
  2. Bligh-Glover W, Kolli TN, Shapiro-Kulnane L, Dilley GE, Friedman L, Balraj E, Rajkowska G, Stockmeier CA. The serotonin transporter in the midbrain of suicide victims with major depression. Biol Psychiatry 2000; 47: 1015–1024.PubMedCrossRefGoogle Scholar
  3. Bourne HR, Bunney WE JR, Colburn RW, Davis JM, Davis JN, Shaw DM, Coppen AJ. Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. Lancet 1968; 2: 805–808.PubMedCrossRefGoogle Scholar
  4. Burnet PW, Harrison PJ. Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia. Biol Psychiatry 2000; 47: 80–83.PubMedCrossRefGoogle Scholar
  5. Caberlotto L, Hurd YL. Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. Neuroreport 1999; 10: 1747–1750.PubMedCrossRefGoogle Scholar
  6. Coppen A, Shaw DM, Malleson A, Eccleston E, Gundy G. Tryptamine metabolism in depression. Br J Psychiatry 1965; 111: 993–998.PubMedCrossRefGoogle Scholar
  7. Cheetham SC, Crompton MR, Katona CL, Parker SJ, Horton RW. Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims. Brain Res 1988; 460: 114–123.PubMedCrossRefGoogle Scholar
  8. Cross JA, Cheetham SC, Crompton MR, Katona CL, Horton RW. Brain GABAB binding sites in depressed suicide victims. Psychiatry Res 1988; 26: 119–129.PubMedCrossRefGoogle Scholar
  9. Gabilondo AM, Meana JJ, Garcia-Sevilla JA. Increased density of mu-opioid receptors in the postmortem brain of suicide victims. Brain Res 1995; 682: 245–250.PubMedCrossRefGoogle Scholar
  10. Gross-Isseroff R, Dillon KA, Israeli M, Biegon A. Regionally selective increases in mu opioid receptor density in the brains of suicide victims. Brain Res 1990; 530: 312–316.PubMedCrossRefGoogle Scholar
  11. Harro J, Marcusson J, Oreland L. Alterations in brain cholecystokinin receptors in suicide victims. Eur Neuropsychopharmacol 1992; 2: 57–63.PubMedCrossRefGoogle Scholar
  12. Honer WG, Falkai P, Chen C, Arango V, Mann JJ, Dwork AJ. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 1999; 91: 1247–1255.PubMedCrossRefGoogle Scholar
  13. Hucks D, Lowther S, Crompton MR, Katona CL, Horton RW. Corticotropin-releasing factor binding sites in cortex of depressed suicides. Psychopharmacology (Berl) 1997; 134: 174178.Google Scholar
  14. Hurd YL, Herman MM, Hyde TM, Bigelow LB, Weinberger DR, Kleinman JE. Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects. Mol Psychiatry 1997; 2: 495–500.PubMedCrossRefGoogle Scholar
  15. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF, Yolken RH. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry 2000; 5: 142–149.PubMedCrossRefGoogle Scholar
  16. Jorgensen OS, Riederer P. Increased synaptic markers in hippocampus of depressed patients. J Neural Transm 1985; 64: 55–66.PubMedCrossRefGoogle Scholar
  17. Kauhanen J, Karvonen MK, Pesonen U, Koulu M, Tuomainen TP, Uusitupa MI, Salonen JT. Neuropeptide Y polymorphism and alcohol consumption in middle-aged men. Am J Med Genet 2000; 93: 117–121.PubMedCrossRefGoogle Scholar
  18. Miguel-Hidalgo JJ, Baucom C, Dilley G, Overholser JC, Meltzer HY, Stockmeier CA, Rajkowska G. Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry 2000; 48: 861–873.PubMedCrossRefGoogle Scholar
  19. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 1988; 45: 577–579PubMedCrossRefGoogle Scholar
  20. Nowak G, Ordway GA, Paul IA. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 1995; 675: 157–164.PubMedCrossRefGoogle Scholar
  21. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 1998; 95: 13290–13295.PubMedCrossRefGoogle Scholar
  22. Ordway GA, Stockmeier CA, Meltzer HY, Overholser JC, Jaconetta S, Widdowson PS. Neuropeptide Y in frontal cortex is not altered in major depression. J Neurochem 1995; 65: 1646–1650.PubMedCrossRefGoogle Scholar
  23. Pare CM, Yeung DP, Price K, Stacey RS. 5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning. Lancet 1969; 2: 133–135.PubMedCrossRefGoogle Scholar
  24. Parker G. Classifying depression: should paradigms lost be regained? Am J Psychiatry 2000; 157: 1195–1203.PubMedCrossRefGoogle Scholar
  25. Perry RH, Dockray GJ, Dimaline R, Perry EK, Blessed G, Tomlinson BE. Neuropeptides in Alzheimer’s disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex. J Neurol Sci 1981; 51: 465–472.PubMedCrossRefGoogle Scholar
  26. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994; 60: 436–444.PubMedCrossRefGoogle Scholar
  27. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer’s disease and depression. Am J Psychiatry 1995; 152: 1372–1376.PubMedGoogle Scholar
  28. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC, Roth BL, Stockmeier CA. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45: 1085–1098.PubMedCrossRefGoogle Scholar
  29. Rochet T, Tonon MC, Kopp N, Vaudry H, Miachon S. Evaluation of endozepine-like immunoreactivity in the frontal cortex of suicide victims. Neuroreport 1998; 9: 53–56.PubMedCrossRefGoogle Scholar
  30. Rupniak NM, Kramer MS. Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 1999; 20: 485–490.PubMedCrossRefGoogle Scholar
  31. Shaw DM, Camps FE, Eccleston EG. 5-Hydroxytryptamine in the hind-brain of depressive suicides. Br J Psychiatry 1967; 113: 1407–1411.PubMedCrossRefGoogle Scholar
  32. Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965; 122: 509–522.PubMedGoogle Scholar
  33. Steckler T, Holsboer F, Reul JM. Glucocorticoids and depression. Baillieres Best Pract Res Clin Endocrinol Metab 1999; 13: 597–614.PubMedCrossRefGoogle Scholar
  34. Sundman I, Allard P, Eriksson A, Marcusson J. GABA uptake sites in frontal cortex from suicide victims and in aging. Neuropsychobiology 1997; 35: 11–15.PubMedCrossRefGoogle Scholar
  35. Thiele TE, Marsh DJ, Ste Marie L, Bernstein IL, Palmiter RD. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 1998; 396: 366–369.PubMedCrossRefGoogle Scholar
  36. Thomas AI, Ferrier IN, Kalaria RN, Woodward SA, Ballard C, Oakley A, Perry RH, O’Brien JT. Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. Am J Psychiatry 2000; 157: 1682–1684.PubMedCrossRefGoogle Scholar
  37. Vawter MP, Hemperly JJ, Hyde TM, Bachus SE, Vanderputten DM, Howard AL, Cannon-Spoor HE, McCoy MT, Webster MI, Kleinman JE, Freed WI. VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophrenia. Exp Neurol 1998; 154: 1–11.PubMedCrossRefGoogle Scholar
  38. Vawter MP, Howard AL, Hyde TM, Kleinman JE, Freed WJ. Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia. Mol Psychiatry 1999; 4: 467–475.PubMedCrossRefGoogle Scholar
  39. Videbech P. MRI findings in patients with affective disorder: a meta-analysis. Acta Psychiatr Scand 1997; 96: 157–168.PubMedCrossRefGoogle Scholar
  40. Webster MI, Vawter MP, Freed WI. Immunohistochemical localization of the cell adhesion molecules Thy-1 and L1 in the human prefrontal cortex patients with schizophrenia, bipolar disorder, and depression. Mol Psychiatry 1999; 4: 46–52.PubMedCrossRefGoogle Scholar
  41. Widdowson PS, Ordway GA, Halaris AE. Reduced neuropeptide Y concentrations in suicide brain. J Neurochem 1992; 59: 73–80.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Dan Rujescu
  • Peter Riederer

There are no affiliations available

Personalised recommendations